Dedicated To Delivering Accountability, Maximizing Compensation And Facilitating Your Recovery

Pfizer Halts Distribution of Anti-smoking Drug After Finding Carcinogen

On Behalf of | Jul 7, 2021 | Uncategorized


Drug manufacturer Pfizer announced that it is pausing distribution of its anti-smoking medication, Chantix, after elevated levels of cancer-causing agents called nitrosamines were found in the pills.

At this time, Pfizer has not announced which nitrosamines were found in Chantix or how they got into the pills.


Chantix is a prescribed medication that aids with quitting smoking. Pfizer halted production of the drug after elevated levels of carcinogens were found in the pills.

Currently, the FDA has not issued a recall on Chantix. Pfizer has temporarily halted the production and distribution of the medication out of an abundance of caution, and plans to thoroughly investigate this issue.

Chantix is a prescribed medication that aids with quitting smoking. It is approved by the FDA for use in adults ages 18 and up.

Consult a Pharmaceutical Liability Attorney

Under federal regulation, consumers are entitled to a level of safety from the manufacturers of the medications they are prescribed, especially when these medications are marketed to enhance an individual’s quality of life. If you or someone you love has been prescribed Chantix and may have been impacted by the quality of the medication, you may be entitled to compensation through a class action lawsuit. Consult with an experienced Pharmaceutical Liability attorney at Sullivan Papain McGrath Coffinas and Cannavo P.C by calling 410-216-0009or filling out the form below for your free consultation.